These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32051182)

  • 1. ESR/ERS statement paper on lung cancer screening.
    Kauczor HU; Baird AM; Blum TG; Bonomo L; Bostantzoglou C; Burghuber O; Čepická B; Comanescu A; Couraud S; Devaraj A; Jespersen V; Morozov S; Nardi Agmon I; Peled N; Powell P; Prosch H; Ravara S; Rawlinson J; Revel MP; Silva M; Snoeckx A; van Ginneken B; van Meerbeeck JP; Vardavas C; von Stackelberg O; Gaga M;
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 32051182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESR/ERS statement paper on lung cancer screening.
    Kauczor HU; Baird AM; Blum TG; Bonomo L; Bostantzoglou C; Burghuber O; Čepická B; Comanescu A; Couraud S; Devaraj A; Jespersen V; Morozov S; Agmon IN; Peled N; Powell P; Prosch H; Ravara S; Rawlinson J; Revel MP; Silva M; Snoeckx A; van Ginneken B; van Meerbeeck JP; Vardavas C; von Stackelberg O; Gaga M;
    Eur Radiol; 2020 Jun; 30(6):3277-3294. PubMed ID: 32052170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESR/ERS white paper on lung cancer screening.
    Kauczor HU; Bonomo L; Gaga M; Nackaerts K; Peled N; Prokop M; Remy-Jardin M; von Stackelberg O; Sculier JP; ;
    Eur Respir J; 2015 Jul; 46(1):28-39. PubMed ID: 25929956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESR/ERS white paper on lung cancer screening.
    Kauczor HU; Bonomo L; Gaga M; Nackaerts K; Peled N; Prokop M; Remy-Jardin M; von Stackelberg O; Sculier JP; ;
    Eur Radiol; 2015 Sep; 25(9):2519-31. PubMed ID: 25929939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milestones towards lung cancer screening implementation.
    Silva M; Milanese G; Kauczor HU; Revel MP; Sverzellati N
    Clin Radiol; 2020 Dec; 75(12):881-885. PubMed ID: 32863024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement.
    Rivera MP; Tanner NT; Silvestri GA; Detterbeck FC; Tammemägi MC; Young RP; Slatore CG; Caverly TJ; Boyd CM; Braithwaite D; Fathi JT; Gould MK; Iaccarino JM; Malkoski SP; Mazzone PJ; Tanoue LT; Schoenborn NL; Zulueta JJ; Wiener RS;
    Am J Respir Crit Care Med; 2018 Jul; 198(2):e3-e13. PubMed ID: 30004250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus statement on a screening programme for the detection of early lung cancer in Poland.
    Rzyman W; Didkowska J; Dziedzic R; Grodzki T; Orłowski T; Szurowska E; Langfort R; Biernat W; Kowalski D; Dyszkiewicz W; Jędrzejczyk T; Zdrojewski T; Nawrocki S; Jassem E; Adamek M
    Adv Respir Med; 2018; 86(1):53-74. PubMed ID: 29490422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors.
    Seaman AT; Dukes K; Hoffman RM; Christensen AJ; Kendell N; Sussman AL; Veléz-Bermúdez M; Volk RJ; Pagedar NA
    Patient Educ Couns; 2018 Oct; 101(10):1741-1747. PubMed ID: 29709410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
    Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
    Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the information needs of lung cancer screening participants: a qualitative study.
    Ruparel M; Quaife S; Baldwin D; Waller J; Janes S
    BMJ Open Respir Res; 2019; 6(1):e000448. PubMed ID: 31803474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When Is a Harm a Harm? Discordance between Patient and Medical Experts' Evaluation of Lung Cancer Screening Attributes.
    Schapira MM; Rodriguez KL; Chhatre S; Fraenkel L; Bastian LA; Kravetz JD; Asan O; Akers S; Vachani A; Prigge JM; Meline J; Ibarra JV; Corn B; Kaminstein D
    Med Decis Making; 2021 Apr; 41(3):317-328. PubMed ID: 33554740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European position statement on lung cancer screening.
    Oudkerk M; Devaraj A; Vliegenthart R; Henzler T; Prosch H; Heussel CP; Bastarrika G; Sverzellati N; Mascalchi M; Delorme S; Baldwin DR; Callister ME; Becker N; Heuvelmans MA; Rzyman W; Infante MV; Pastorino U; Pedersen JH; Paci E; Duffy SW; de Koning H; Field JK
    Lancet Oncol; 2017 Dec; 18(12):e754-e766. PubMed ID: 29208441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
    Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
    Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.
    Black C; Bagust A; Boland A; Walker S; McLeod C; De Verteuil R; Ayres J; Bain L; Thomas S; Godden D; Waugh N
    Health Technol Assess; 2006 Jan; 10(3):iii-iv, ix-x, 1-90. PubMed ID: 16409881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Shared Decision Making for Lung Cancer Screening.
    Brenner AT; Malo TL; Margolis M; Elston Lafata J; James S; Vu MB; Reuland DS
    JAMA Intern Med; 2018 Oct; 178(10):1311-1316. PubMed ID: 30105393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.